← Leaderboards
Raymond F Muzic
Case Western Reserve University
$5,871,932
Attributed
$6,785,299
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $824.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,785,299 · 11
By mechanism
R01$4,805,542 · 3
R33$873,970 · 1
R21$841,909 · 2
P30$260,600 · 3
M01$3,278 · 2
Top collaborators
- Faramarz Ismail-Beigi4 shared
- Norbert E. Avril2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Faramarz Ismail-Beigi$6,031,516
- Scott Michael Welford$5,685,124
- Hillard M Lazarus$3,198,402
- Nora Singer$3,497,199
- Norbert E. Avril$203,772
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseImageIn VivoTissuesPositron-Emission TomographyMalignant NeoplasmsAnimalsBrainBloodRadiationPublic Health RelevanceTreatment ResponseLiverMeasurementMonitorRadiation OncologyNew TechnologyInstitutionBoneProgramsStagingGlucose TransporterGlucose TransportPhosphorylation
Grant awards (25)
Exploring SGLTs as Theranostic Targets for Cancer Metastasis$198,366
R21 · FY2025 · CA · contact PI
Exploring SGLTs as Theranostic Targets for Cancer Metastasis$236,000
R21 · FY2024 · CA · contact PI
Radiation Resources Shared Resource$82,197
P30 · FY2024 · CA · contact PI
Radiation Resources Shared Resource$82,197
P30 · FY2023 · CA · contact PI
Radiation Resources Shared Resource$49,132
P30 · FY2022 · CA · contact PI
Radiation Resources Shared Resource$47,074
P30 · FY2021 · CA · contact PI
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials$439,398
R01 · FY2019 · CA · contact PI
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials$522,225
R01 · FY2018 · CA · contact PI
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials$209,873
R01 · FY2017 · CA · contact PI
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials$602,540
R01 · FY2016 · CA · contact PI
PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer$222,296
R21 · FY2016 · CA
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials$620,305
R01 · FY2015 · CA · contact PI
PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer$185,247
R21 · FY2015 · CA
Novel PET Imaging of Glucose Transport$334,680
R01 · FY2012 · DK · contact PI
Novel PET Imaging of Glucose Transport$334,680
R01 · FY2011 · DK · contact PI
Novel PET Imaging of Glucose Transport$373,032
R01 · FY2010 · DK · contact PI
Novel PET Imaging of Glucose Transport$376,800
R01 · FY2009 · DK · contact PI
COMKAT:Compartment Model Kinetic Analysis/Imaging$274,179
R33 · FY2006 · CA · contact PI
11C TOPOTECAN PET IMAGING$2,749
M01 · FY2006 · RR · contact PI
COMKAT:Compartment Model Kinetic Analysis/Imaging$273,338
R33 · FY2005 · CA
11C TOPOTECAN PET IMAGING$529
M01 · FY2005 · RR
COMKAT:Compartment Model Kinetic Analysis/Imaging$326,453
R33 · FY2004 · CA
QUANTIFICATION OF HEART BETA ADRENERGIC RECEPTORS$368,650
R01 · FY2002 · HL
QUANTIFICATION OF HEART BETA ADRENERGIC RECEPTORS$315,185
R01 · FY2001 · HL
QUANTIFICATION OF HEART BETA ADRENERGIC RECEPTORS$308,174
R01 · FY2000 · HL